in making a decision, as to whether a substance included in schedule 3 of the susdp may be advertised to the public, the ndpsc will consider the following matters:- &#8226; the potential public health benefit.
the committee agrees that the current scheduling of orlistat remains appropriate but that the current regulations in part 3 of the susdp require revision.
denial of natural justice 136 it is not clear that roche pressed its grounds of review that the october 2006 and the february 2007 decisions of the committee involved breaches of the rules of natural justice.